Related Experiment Video
Updated: Jul 9, 2026

Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092
Published on: October 2, 2017
Common alterations in PBP1a from resistant Streptococcus pneumoniae decrease its reactivity toward beta-lactams:
Viviana Job1, Raphaël Carapito, Thierry Vernet
1Laboratoire des Protéines Membranaires, Institut de Biologie Structurale Jean-Pierre Ebel, Université Joseph Fourier, UMR 5075-CNRS, CEA Grenoble, France.
Abstract:
The development of high level beta-lactam resistance in the pneumococcus requires the expression of an altered form of PBP1a, in addition to modified forms of PBP2b and PBP2x, which are necessary for the appearance of low levels of resistance. Here, we present the crystal structure of a soluble form of PBP1a from the highly resistant Streptococcus pneumoniae strain 5204 (minimal inhibitory concentration of cefotaxime is 12 mg.liter(-1)). Mutations T371A, which is adjacent to the catalytic nucleophile Ser370, and TSQF(574-577)NTGY, which lie in a loop bordering the active site cleft, were investigated by site-directed mutagenesis. The consequences of these substitutions on reaction kinetics with beta-lactams were probed in vitro, and their effect on resistance was measured in vivo. The results are interpreted in the framework of the crystal structure, which displays a narrower, discontinuous active site cavity, compared with that of PBP1a from the beta-lactam susceptible strain R6, as well as a reorientation of the catalytic Ser370.
Insights
High-level beta-lactam resistance in Streptococcus pneumoniae involves altered PBP1a. Structural analysis reveals a narrower active site cavity and reoriented catalytic residue in resistant strains, impacting drug efficacy.
Area of Science:
- Microbiology
- Structural Biology
- Drug Resistance
Background:
- Penicillin-binding proteins (PBPs) are crucial targets for beta-lactam antibiotics.
- High-level beta-lactam resistance in Streptococcus pneumoniae necessitates alterations in multiple PBPs, including PBP1a, PBP2b, and PBP2x.
Purpose of the Study:
- To elucidate the structural basis of high-level beta-lactam resistance in Streptococcus pneumoniae.
- To investigate the role of specific mutations in PBP1a on beta-lactam resistance.
Main Methods:
- Crystal structure determination of soluble PBP1a from a resistant strain (S. pneumoniae 5204).
- Site-directed mutagenesis to introduce specific PBP1a mutations (T371A and TSQF(574-577)NTGY).
- In vitro kinetic analysis and in vivo resistance measurements.
Main Results:
- The crystal structure of PBP1a from resistant S. pneumoniae 5204 revealed a narrower, discontinuous active site cavity compared to susceptible strains.
- A reorientation of the catalytic residue Ser370 was observed in the resistant PBP1a structure.
- Investigated mutations (T371A and TSQF(574-577)NTGY) showed altered reaction kinetics and affected resistance levels.
Conclusions:
- Structural modifications in PBP1a contribute significantly to high-level beta-lactam resistance in Streptococcus pneumoniae.
- The altered active site cavity and catalytic residue reorientation are key factors in reduced antibiotic susceptibility.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Atypical Pneumonia
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

